Скачать презентацию Since 1614 400 years of Passion Performance Скачать презентацию Since 1614 400 years of Passion Performance

85d8ac05d238d25b91bebd500ae25f27.ppt

  • Количество слайдов: 16

Since 1614 400 years of Passion & Performance 3/16/2018 | 1 Dutch Universities: Research Since 1614 400 years of Passion & Performance 3/16/2018 | 1 Dutch Universities: Research with Focus on Top Sectors. Cooperation with Russia in Field of Life-Science & Health Sibrandes Poppema

Scientific output 2002 -2012 3/16/2018 | 2 1. 2. 3. 4. 5. 6. 7. Scientific output 2002 -2012 3/16/2018 | 2 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. USA PEOPLES REP CHINA GERMANY JAPAN ENGLAND FRANCE CANADA ITALY SPAIN AUSTRALIA INDIA SOUTH KOREA NETHERLANDS RUSSIA 3, 250, 380 1, 022, 597 845, 448 803, 857 747, 867 603, 328 493, 736 470, 648 382, 658 338, 947 334, 660 325, 403 276, 918 275, 325 51, 546, 027 6, 653, 426 11, 340, 845 8, 390, 864 11, 306, 492 7, 556, 253 6, 588, 762 5, 689, 120 4, 079, 695 4, 098, 351 2, 059, 832 2, 385, 604 4, 376, 263 1, 371, 065 15. 86 6. 51 13. 41 10. 44 15. 12 12. 52 13. 34 12. 09 10. 66 12. 09 6. 15 7. 33 15. 80 4. 98

University rankings 3 Nature Publishing Index: 85 Scientist Best Places to Work in Academia: University rankings 3 Nature Publishing Index: 85 Scientist Best Places to Work in Academia: 24 New York Times Employability: 81 Publications In Nature or Science

University-Business cooperation (Netherlands) 3/16/2018 | 4 q Public-Private Partnerships in top-institutes (investigator driven, precompetitive University-Business cooperation (Netherlands) 3/16/2018 | 4 q Public-Private Partnerships in top-institutes (investigator driven, precompetitive with industry) q Intermediate (industry driven, with investigators) q New: top-sector policy (9 areas, government policy). Horticulture Agri & Food Water Life sciences & Health Chemistry High tech Energy Logistics Creative industry Head offices

Topsector Life Sciences Healthy Ageing Source: Topsectorplan Life Sciences and Health Topsector Life Sciences Healthy Ageing Source: Topsectorplan Life Sciences and Health

University Medical Center 1797 3/16/2018 | 6 University Medical Center 1797 3/16/2018 | 6

Zernike Science Campus 3/16/2018 | 7 Zernike Science Campus 3/16/2018 | 7

Relevance to Society Multidisciplinary, University, Industry, Governments & Public Participation 1. Healthy ageing (HANNN) Relevance to Society Multidisciplinary, University, Industry, Governments & Public Participation 1. Healthy ageing (HANNN) • Biobank & Cohort study Lifelines (165, 000 participants) • European Research Institute on the Biology of Ageing ERIBA 2. Energy (Energy Valley) • Energy Academy Europe EAE • Energy Delta Institute EDI • Groningen Centre of Energy Law Energy Academy Europe 3. Sustainable Society ENTRANCE: multitesting facility

Healthy Ageing: Life. Lines www. lifelines. nl Relative contributions of genetics and life style Healthy Ageing: Life. Lines www. lifelines. nl Relative contributions of genetics and life style to health and disease Life. Lines is a prospective cohort study and Biobank that will follow 165, 000 participants in a 3 -generation design for at least 30 years. The focus is on multifactorial, agerelated disorders. Funding: ~120 Million Euro September 2012: 100. 000 th participant

Healthy Ageing: Life. Lines cohort dimensions father www. lifelines. nl Aselect: 45. 000 Index Healthy Ageing: Life. Lines cohort dimensions father www. lifelines. nl Aselect: 45. 000 Index persons (25 -50 years) Children: 35. 000 mother child Parents alive: 55. 000 child partner’s father partner’s mother Partner: 30. 000 Total number of participants: 165. 000

European Research Institute on the Biology of Ageing ERIBA Fundamental questions on the biological European Research Institute on the Biology of Ageing ERIBA Fundamental questions on the biological causes of stem cell ageing

Healthy Ageing European Research Institute on the Biology of Ageing Dr. Peter Lansdorp Scientific Healthy Ageing European Research Institute on the Biology of Ageing Dr. Peter Lansdorp Scientific Director Team Leader: Laboratory of Genetic Instability, Ageing and Cancer ERC advanced grant 2011 Dr. Ellen Nollen Team Leader: Laboratory of Molecular Neurobiology of Ageing ERC starting grant 2011 Dr. Gerald de Haan Dr. Victor Guryev Scientific Co-Director Team Leader: Laboratory of Ageing Biology and Stem Cells Team Leader: Laboratory of Genome Structure and Ageing Dr. Michael Chang Dr. Floris Foijer Team Leader: Laboratory of Telomeres and Genome Integrity Team Leader: Laboratory of Genomic Instability in Development and Disease Dr. Eugene Berezikov Dr. Liesbeth Veenhoff Team Leader: Laboratory of Stem Cell Regulation and Mechanisms of Regeneration ERC starting grant 2012 Team Leader: Laboratory of Cellular Biochemistry: Role of nuclear transport in cellular ageing Dr. Christian Riedel Team Leader: Laboratory of Molecular Mechanisms in Lifespan Regulation. International team, prestigious European ERC grants

Alliance for Healthy Ageing with Mayo Clinics Clearance of p 16 Ink 4 a-positive Alliance for Healthy Ageing with Mayo Clinics Clearance of p 16 Ink 4 a-positive senescent cells delays ageing-associated disorders Darren J. Baker, Tobias Wijshake, Tamar Tchkonia, Nathan K. Le. Brasseur, Bennett G. Childs, Bart van de Sluis, James L. Kirkland & Jan M. Van Deursen Nature 479, 232– 236 (10 November 2011) Prevents ageing: kyphosis, cataract etc According to Science one of the top 10 scientific discoveries of 2011

Skolkovo Tech Research Investment Strategy Skolkovo Institute of Science and Technology 2012 3/16/2018 | Skolkovo Tech Research Investment Strategy Skolkovo Institute of Science and Technology 2012 3/16/2018 | 14

Skolkovo Tech Strategy – Bio. Medicine (1) 3/16/2018 | 15 Computational and systems biology Skolkovo Tech Strategy – Bio. Medicine (1) 3/16/2018 | 15 Computational and systems biology – profoundly different approaches to study biological systems, including complex data, in order to support both basic, as well as applied research involving discovery of new drugs and drug targets [high priority] Immunology and infectious disease - in terms of diseases caused by multi-drug resistant bacteria and viral pandemics, the role of microbiome in human health, and organized response to and treatment of disease [high priority, center in negotiation] Gene- and nano-medicine - impacting the understanding of disease, therapeutics and drug delivery [high priority, center in negotiation] Regenerative medicine - stem cell research as well as tissue and organ fabrication [high priority, center in negotiation with ERIBA, University of Groningen]

Hey Charles, Where are you going? To the University of Groningen, always good to Hey Charles, Where are you going? To the University of Groningen, always good to get some additional schooling THANK YOU FOR YOUR ATTENTION 3/16/2018 | 16